BRIEF-EMA Says Clinical Data Published Supporting Extension Of Indication For Spikevax To Include Use In Adolescents Aged 12-17

Reuters | Updated: 25-01-2022 21:47 IST | Created: 25-01-2022 21:30 IST

BRIEF-EMA Says Clinical Data Published Supporting Extension Of Indication For Spikevax To Include Use In Adolescents Aged 12-17 — Image Credit:

European Medicines Agency:

* EMA PUBLISHED CLINICAL DATA SUPPORTING EXTENSION OF INDICATION FOR SPIKEVAX TO INCLUDE USE IN ADOLESCENTS AGED 12 TO 17. Further company coverage:

TRENDING

1

Lula ahead in polls for Brazil's first-round vote; runoff likely

Lula ahead in polls for Brazil's first-round vote; runoff likely

Global

2

Trump tries to fire up Ohio voters as Republicans defend Senate seat in close race

Trump tries to fire up Ohio voters as Republicans defend Senate seat in clos...

Global

3

Lula ahead in polls for Brazil's first-round vote; runoff likely

Lula ahead in polls for Brazil's first-round vote; runoff likely

Global

4

Latvia PM Kulbergs wins election held under shadow of Ukraine war

Latvia PM Kulbergs wins election held under shadow of Ukraine war

Global

PERSPECTIVES AND INSIGHTS

Himachal’s Natural Apple Farming Boom Reveals What Growers Need to Keep It Growing

Chemical Trail We Leave Behind: Everyday Water Use Adds Hidden TFA to Sewers

Better Schools, Stronger Economy: Saudi Arabia Eyes a Major Growth Dividend From Education

Beyond Speed: Peru’s AI Experiment Shows Why Teacher Skills Matter More Than Technology Access

DevShots

Latest News

Connect us on

Facebook Twitter LinkedIn Quora Youtube

Google News RSS

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

Name

Email

Message

By submitting, you agree that we may use your email address to respond.

Web Analytics Made Easy - Statcounter